<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "verteporfin inj VIAL>
<dose><value>6</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drug><value>verteporfin inj VIAL</value>
</drug><strength><value>15 mg</value>
</strength><frequency><value>ONCE</value>
</frequency><instruction><value>Administer dose over 10 minutes.</value>
</instruction><volume><value></value>
</volume><units><value>mg/m2</value>
</units><additionalnotes><value>AHS Drug Formulary: Restricted to Specialized High Cost Drug program criteria: treatment of age-related macular degeneration in patients with predominantly (&amp;gt;50%) subfoveal choroidal neovascularization. Must be prescribed by a Retina Specialist. </value>
</additionalnotes><population><value></value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3003</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>EENT Drugs, Miscellaneous</value>
</ahfsname><highalert><value></value>
</highalert><maximumprndose><value></value>
</maximumprndose></drug>